The Risk of Recurrent Anaphylaxis

Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphyla...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 2017-01, Vol.180, p.217-221
Hauptverfasser: O'Keefe, Andrew, MD, Clarke, Ann, MD, MSc, St. Pierre, Yvan, MSc, Mill, Jennifer, BA, Asai, Yuka, MD, MSc, Eisman, Harley, MD, La Vieille, Sebastien, MD, Alizadehfar, Reza, MD, Joseph, Lawrence, PhD, Morris, Judy, MD, Gravel, Jocelyn, MD, Ben-Shoshan, Moshe, MD, MSc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 221
container_issue
container_start_page 217
container_title The Journal of pediatrics
container_volume 180
creator O'Keefe, Andrew, MD
Clarke, Ann, MD, MSc
St. Pierre, Yvan, MSc
Mill, Jennifer, BA
Asai, Yuka, MD, MSc
Eisman, Harley, MD
La Vieille, Sebastien, MD
Alizadehfar, Reza, MD
Joseph, Lawrence, PhD
Morris, Judy, MD
Gravel, Jocelyn, MD
Ben-Shoshan, Moshe, MD, MSc
description Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphylaxis. Study design As part of the Cross-Canada Anaphylaxis Registry, parents of children with anaphylaxis identified prospectively in 3 EDs and through an emergency medical response service were contacted annually after presentation and queried on subsequent reactions. Cox regression analysis determined factors associated with recurrence. Results Among 292 children who were registered as having had medical attended anaphylaxis, 68.5% completed annual follow-up questionnaires. Forty-seven patients experienced 65 episodes of anaphylaxis during 369 patient-years of follow-up. Food was the trigger in 84.6% of cases, and epinephrine was used in 66.2%. In 50.8%, epinephrine was used outside the health care facility, and 81.7% were brought to a health care facility for treatment. Asthma, reaction triggered by food, and use of epinephrine during the index episode increased the odds of recurrent reaction. Patients whose initial reaction was triggered by peanut were less likely to have a recurrent reaction. Conclusions We report a yearly anaphylaxis recurrence rate of 17.6% in children. There is substantial underuse of epinephrine in cases of anaphylaxis. Educational programs that promote effective avoidance strategies and prompt use of epinephrine are required.
doi_str_mv 10.1016/j.jpeds.2016.09.028
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835430760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022347616309386</els_id><sourcerecordid>1835430760</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-90e68269b87f8c52b989e30db0d5bfac0a544a98d3031085ad822853751311073</originalsourceid><addsrcrecordid>eNqFkc1Lw0AQxRdRbK3-BYLUm5fE2d187B4USvELBKHW87LZTOimaVJ3E7H_vamtHrx4Ggbem8f8HiHnFEIKNLkuw3KNuQ9Zv4QgQ2DigAwpyDRIBOeHZAjAWMCjNBmQE-9LAJARwDEZsDSNeCzZkFzOFzieWb8cN8V4hqZzDut2PKn1erGp9Kf1p-So0JXHs_0ckbf7u_n0MXh-eXiaTp4DE9GoDSRgIlgiM5EWwsQsk0IihzyDPM4KbUDHUaSlyDlwCiLWuWBMxDyNKacUUj4iV7u7a9e8d-hbtbLeYFXpGpvOKyp4HHFIE-ilfCc1rvHeYaHWzq602ygKastGleqbjdqyUSBVz6Z3XewDumyF-a_nB0YvuNkJsH_zw6JT3lisDebWoWlV3th_Am7_-E1la2t0tcQN-rLpXN0TVFR5pkC9buvZtkMTDpKLhH8B_ZqHvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835430760</pqid></control><display><type>article</type><title>The Risk of Recurrent Anaphylaxis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>O'Keefe, Andrew, MD ; Clarke, Ann, MD, MSc ; St. Pierre, Yvan, MSc ; Mill, Jennifer, BA ; Asai, Yuka, MD, MSc ; Eisman, Harley, MD ; La Vieille, Sebastien, MD ; Alizadehfar, Reza, MD ; Joseph, Lawrence, PhD ; Morris, Judy, MD ; Gravel, Jocelyn, MD ; Ben-Shoshan, Moshe, MD, MSc</creator><creatorcontrib>O'Keefe, Andrew, MD ; Clarke, Ann, MD, MSc ; St. Pierre, Yvan, MSc ; Mill, Jennifer, BA ; Asai, Yuka, MD, MSc ; Eisman, Harley, MD ; La Vieille, Sebastien, MD ; Alizadehfar, Reza, MD ; Joseph, Lawrence, PhD ; Morris, Judy, MD ; Gravel, Jocelyn, MD ; Ben-Shoshan, Moshe, MD, MSc</creatorcontrib><description>Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphylaxis. Study design As part of the Cross-Canada Anaphylaxis Registry, parents of children with anaphylaxis identified prospectively in 3 EDs and through an emergency medical response service were contacted annually after presentation and queried on subsequent reactions. Cox regression analysis determined factors associated with recurrence. Results Among 292 children who were registered as having had medical attended anaphylaxis, 68.5% completed annual follow-up questionnaires. Forty-seven patients experienced 65 episodes of anaphylaxis during 369 patient-years of follow-up. Food was the trigger in 84.6% of cases, and epinephrine was used in 66.2%. In 50.8%, epinephrine was used outside the health care facility, and 81.7% were brought to a health care facility for treatment. Asthma, reaction triggered by food, and use of epinephrine during the index episode increased the odds of recurrent reaction. Patients whose initial reaction was triggered by peanut were less likely to have a recurrent reaction. Conclusions We report a yearly anaphylaxis recurrence rate of 17.6% in children. There is substantial underuse of epinephrine in cases of anaphylaxis. Educational programs that promote effective avoidance strategies and prompt use of epinephrine are required.</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/j.jpeds.2016.09.028</identifier><identifier>PMID: 27743592</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>anaphylaxis ; Anaphylaxis - drug therapy ; Anaphylaxis - epidemiology ; Child ; Emergency Service, Hospital ; Emergency Treatment ; epinephrine ; Epinephrine - therapeutic use ; Female ; food allergy ; Humans ; Male ; Pediatrics ; Prospective Studies ; Recurrence ; risk ; Risk Assessment</subject><ispartof>The Journal of pediatrics, 2017-01, Vol.180, p.217-221</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-90e68269b87f8c52b989e30db0d5bfac0a544a98d3031085ad822853751311073</citedby><cites>FETCH-LOGICAL-c414t-90e68269b87f8c52b989e30db0d5bfac0a544a98d3031085ad822853751311073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022347616309386$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27743592$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Keefe, Andrew, MD</creatorcontrib><creatorcontrib>Clarke, Ann, MD, MSc</creatorcontrib><creatorcontrib>St. Pierre, Yvan, MSc</creatorcontrib><creatorcontrib>Mill, Jennifer, BA</creatorcontrib><creatorcontrib>Asai, Yuka, MD, MSc</creatorcontrib><creatorcontrib>Eisman, Harley, MD</creatorcontrib><creatorcontrib>La Vieille, Sebastien, MD</creatorcontrib><creatorcontrib>Alizadehfar, Reza, MD</creatorcontrib><creatorcontrib>Joseph, Lawrence, PhD</creatorcontrib><creatorcontrib>Morris, Judy, MD</creatorcontrib><creatorcontrib>Gravel, Jocelyn, MD</creatorcontrib><creatorcontrib>Ben-Shoshan, Moshe, MD, MSc</creatorcontrib><title>The Risk of Recurrent Anaphylaxis</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphylaxis. Study design As part of the Cross-Canada Anaphylaxis Registry, parents of children with anaphylaxis identified prospectively in 3 EDs and through an emergency medical response service were contacted annually after presentation and queried on subsequent reactions. Cox regression analysis determined factors associated with recurrence. Results Among 292 children who were registered as having had medical attended anaphylaxis, 68.5% completed annual follow-up questionnaires. Forty-seven patients experienced 65 episodes of anaphylaxis during 369 patient-years of follow-up. Food was the trigger in 84.6% of cases, and epinephrine was used in 66.2%. In 50.8%, epinephrine was used outside the health care facility, and 81.7% were brought to a health care facility for treatment. Asthma, reaction triggered by food, and use of epinephrine during the index episode increased the odds of recurrent reaction. Patients whose initial reaction was triggered by peanut were less likely to have a recurrent reaction. Conclusions We report a yearly anaphylaxis recurrence rate of 17.6% in children. There is substantial underuse of epinephrine in cases of anaphylaxis. Educational programs that promote effective avoidance strategies and prompt use of epinephrine are required.</description><subject>anaphylaxis</subject><subject>Anaphylaxis - drug therapy</subject><subject>Anaphylaxis - epidemiology</subject><subject>Child</subject><subject>Emergency Service, Hospital</subject><subject>Emergency Treatment</subject><subject>epinephrine</subject><subject>Epinephrine - therapeutic use</subject><subject>Female</subject><subject>food allergy</subject><subject>Humans</subject><subject>Male</subject><subject>Pediatrics</subject><subject>Prospective Studies</subject><subject>Recurrence</subject><subject>risk</subject><subject>Risk Assessment</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1Lw0AQxRdRbK3-BYLUm5fE2d187B4USvELBKHW87LZTOimaVJ3E7H_vamtHrx4Ggbem8f8HiHnFEIKNLkuw3KNuQ9Zv4QgQ2DigAwpyDRIBOeHZAjAWMCjNBmQE-9LAJARwDEZsDSNeCzZkFzOFzieWb8cN8V4hqZzDut2PKn1erGp9Kf1p-So0JXHs_0ckbf7u_n0MXh-eXiaTp4DE9GoDSRgIlgiM5EWwsQsk0IihzyDPM4KbUDHUaSlyDlwCiLWuWBMxDyNKacUUj4iV7u7a9e8d-hbtbLeYFXpGpvOKyp4HHFIE-ilfCc1rvHeYaHWzq602ygKastGleqbjdqyUSBVz6Z3XewDumyF-a_nB0YvuNkJsH_zw6JT3lisDebWoWlV3th_Am7_-E1la2t0tcQN-rLpXN0TVFR5pkC9buvZtkMTDpKLhH8B_ZqHvA</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>O'Keefe, Andrew, MD</creator><creator>Clarke, Ann, MD, MSc</creator><creator>St. Pierre, Yvan, MSc</creator><creator>Mill, Jennifer, BA</creator><creator>Asai, Yuka, MD, MSc</creator><creator>Eisman, Harley, MD</creator><creator>La Vieille, Sebastien, MD</creator><creator>Alizadehfar, Reza, MD</creator><creator>Joseph, Lawrence, PhD</creator><creator>Morris, Judy, MD</creator><creator>Gravel, Jocelyn, MD</creator><creator>Ben-Shoshan, Moshe, MD, MSc</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170101</creationdate><title>The Risk of Recurrent Anaphylaxis</title><author>O'Keefe, Andrew, MD ; Clarke, Ann, MD, MSc ; St. Pierre, Yvan, MSc ; Mill, Jennifer, BA ; Asai, Yuka, MD, MSc ; Eisman, Harley, MD ; La Vieille, Sebastien, MD ; Alizadehfar, Reza, MD ; Joseph, Lawrence, PhD ; Morris, Judy, MD ; Gravel, Jocelyn, MD ; Ben-Shoshan, Moshe, MD, MSc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-90e68269b87f8c52b989e30db0d5bfac0a544a98d3031085ad822853751311073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>anaphylaxis</topic><topic>Anaphylaxis - drug therapy</topic><topic>Anaphylaxis - epidemiology</topic><topic>Child</topic><topic>Emergency Service, Hospital</topic><topic>Emergency Treatment</topic><topic>epinephrine</topic><topic>Epinephrine - therapeutic use</topic><topic>Female</topic><topic>food allergy</topic><topic>Humans</topic><topic>Male</topic><topic>Pediatrics</topic><topic>Prospective Studies</topic><topic>Recurrence</topic><topic>risk</topic><topic>Risk Assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Keefe, Andrew, MD</creatorcontrib><creatorcontrib>Clarke, Ann, MD, MSc</creatorcontrib><creatorcontrib>St. Pierre, Yvan, MSc</creatorcontrib><creatorcontrib>Mill, Jennifer, BA</creatorcontrib><creatorcontrib>Asai, Yuka, MD, MSc</creatorcontrib><creatorcontrib>Eisman, Harley, MD</creatorcontrib><creatorcontrib>La Vieille, Sebastien, MD</creatorcontrib><creatorcontrib>Alizadehfar, Reza, MD</creatorcontrib><creatorcontrib>Joseph, Lawrence, PhD</creatorcontrib><creatorcontrib>Morris, Judy, MD</creatorcontrib><creatorcontrib>Gravel, Jocelyn, MD</creatorcontrib><creatorcontrib>Ben-Shoshan, Moshe, MD, MSc</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Keefe, Andrew, MD</au><au>Clarke, Ann, MD, MSc</au><au>St. Pierre, Yvan, MSc</au><au>Mill, Jennifer, BA</au><au>Asai, Yuka, MD, MSc</au><au>Eisman, Harley, MD</au><au>La Vieille, Sebastien, MD</au><au>Alizadehfar, Reza, MD</au><au>Joseph, Lawrence, PhD</au><au>Morris, Judy, MD</au><au>Gravel, Jocelyn, MD</au><au>Ben-Shoshan, Moshe, MD, MSc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Risk of Recurrent Anaphylaxis</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>180</volume><spage>217</spage><epage>221</epage><pages>217-221</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><abstract>Objectives To determine the recurrence rate of anaphylaxis in children medically attended in an emergency department (ED), we performed a prospective cohort study to evaluate prehospital and ED management of children with recurrent anaphylaxis and to assess factors associated with recurrent anaphylaxis. Study design As part of the Cross-Canada Anaphylaxis Registry, parents of children with anaphylaxis identified prospectively in 3 EDs and through an emergency medical response service were contacted annually after presentation and queried on subsequent reactions. Cox regression analysis determined factors associated with recurrence. Results Among 292 children who were registered as having had medical attended anaphylaxis, 68.5% completed annual follow-up questionnaires. Forty-seven patients experienced 65 episodes of anaphylaxis during 369 patient-years of follow-up. Food was the trigger in 84.6% of cases, and epinephrine was used in 66.2%. In 50.8%, epinephrine was used outside the health care facility, and 81.7% were brought to a health care facility for treatment. Asthma, reaction triggered by food, and use of epinephrine during the index episode increased the odds of recurrent reaction. Patients whose initial reaction was triggered by peanut were less likely to have a recurrent reaction. Conclusions We report a yearly anaphylaxis recurrence rate of 17.6% in children. There is substantial underuse of epinephrine in cases of anaphylaxis. Educational programs that promote effective avoidance strategies and prompt use of epinephrine are required.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27743592</pmid><doi>10.1016/j.jpeds.2016.09.028</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 2017-01, Vol.180, p.217-221
issn 0022-3476
1097-6833
language eng
recordid cdi_proquest_miscellaneous_1835430760
source MEDLINE; Elsevier ScienceDirect Journals
subjects anaphylaxis
Anaphylaxis - drug therapy
Anaphylaxis - epidemiology
Child
Emergency Service, Hospital
Emergency Treatment
epinephrine
Epinephrine - therapeutic use
Female
food allergy
Humans
Male
Pediatrics
Prospective Studies
Recurrence
risk
Risk Assessment
title The Risk of Recurrent Anaphylaxis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T08%3A37%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Risk%20of%20Recurrent%20Anaphylaxis&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=O'Keefe,%20Andrew,%20MD&rft.date=2017-01-01&rft.volume=180&rft.spage=217&rft.epage=221&rft.pages=217-221&rft.issn=0022-3476&rft.eissn=1097-6833&rft_id=info:doi/10.1016/j.jpeds.2016.09.028&rft_dat=%3Cproquest_cross%3E1835430760%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835430760&rft_id=info:pmid/27743592&rft_els_id=S0022347616309386&rfr_iscdi=true